FI943948A - Heterosykliset hiilihappojohdannaiset - Google Patents

Heterosykliset hiilihappojohdannaiset Download PDF

Info

Publication number: FI943948A
Authority: FI; Finland
Prior art keywords: pct; carbonic acid; acid derivatives; heterocycle; sec
Prior art date: 1992-12-28

Application number

FI943948A

Other languages

English (en)

Swedish (sv)

Other versions

FI943948A0 (fi

Inventor

Hiroyuki Yoshimura

Mitsuo Nagai

Shigeki Hibi

Koichi Kikuchi

Ieharu Hishinuma

Junichi Nagakawa

Makoto Asada

Norimasa Miyamoto

Takayuki Hida

Aichi Ogasawara

Isao Yamatsu

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-28

Filing date

1994-08-26

Publication date

1994-08-26

1994-08-26 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

1994-08-26 Publication of FI943948A publication Critical patent/FI943948A/fi

1994-08-26 Publication of FI943948A0 publication Critical patent/FI943948A0/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/08—Naphthothiopyrans; Hydrogenated naphthothiopyrans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

FI943948A 1992-12-28 1994-08-26 Heterosykliset hiilihappojohdannaiset FI943948A0 (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP35861692		1992-12-28
JP2345093		1993-01-20
PCT/JP1993/001841 WO1994014777A1 (en)	1992-12-28	1993-12-20	Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)

Publications (2)

Publication Number	Publication Date
FI943948A true FI943948A (fi)	1994-08-26
FI943948A0 FI943948A0 (fi)	1994-08-26

Family

ID=26360806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI943948A FI943948A0 (fi)	1992-12-28	1994-08-26	Heterosykliset hiilihappojohdannaiset

Country Status (14)

Country	Link
US (1)	US5612356A (fi)
EP (1)	EP0638071B1 (fi)
JP (2)	JP3476883B2 (fi)
KR (2)	KR0126300B1 (fi)
CN (2)	CN1036920C (fi)
AT (1)	ATE151418T1 (fi)
CA (1)	CA2129846A1 (fi)
DE (1)	DE69309670T2 (fi)
DK (1)	DK0638071T3 (fi)
ES (1)	ES2102195T3 (fi)
FI (1)	FI943948A0 (fi)
GR (1)	GR3024074T3 (fi)
NO (1)	NO304687B1 (fi)
WO (1)	WO1994014777A1 (fi)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW334423B (en) *	1993-10-22	1998-06-21	Hoffmann La Roche	Tricyclic 1-aminoethylpyrrole-derivatives
CN1061036C (zh) *	1993-11-30	2001-01-24	G·D·瑟尔公司	用于治疗炎症的取代的吡唑基苯磺酰胺类化合物
US6492411B1 (en)	1993-11-30	2002-12-10	G. D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5466823A (en)	1993-11-30	1995-11-14	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides
US6716991B1 (en)	1993-11-30	2004-04-06	G. D. Searle & Co.	Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
FR2735371B1 (fr) *	1995-06-19	1997-07-18	Cird Galderma	Procede pour identifier des composes antagonistes des recepteurs rars
US5952345A (en) *	1995-09-01	1999-09-14	Allergan Sales, Inc.	Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5776699A (en) *	1995-09-01	1998-07-07	Allergan, Inc.	Method of identifying negative hormone and/or antagonist activities
US6008204A (en)	1995-09-01	1999-12-28	Allergan Sales, Inc.	Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
HUP9902645A3 (en) *	1996-03-18	1999-12-28	Eisai Co Ltd	Fused-ring carboxylic acid derivatives
FR2753627B1 (fr) *	1996-09-20	2003-02-21	Galderma Rech Dermatologique	Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation
US5728846A (en) *	1996-12-12	1998-03-17	Allergan	Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5919970A (en) *	1997-04-24	1999-07-06	Allergan Sales, Inc.	Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
ES2206997T3 (es)	1997-10-06	2004-05-16	ABBOTT GMBH & CO. KG	Derivados de indeno(1,2-c)-,de nafto(1,2-c),y de benzo(6,7)cicloepta(1,2-c)pirazol.
CN1278724A (zh)	1997-10-06	2001-01-03	巴斯福股份公司	抑制酪氨酸激酶活性的茚并[1,2－c]吡唑衍生物
KR20040031107A (ko) *	1997-11-12	2004-04-09	에프. 호프만-라 로슈 아게	레티노이드 길항제를 이용한 제2형 ｔ-보조세포 중재면역질환의 치료
ES2203246T3 (es) *	1998-09-30	2004-04-01	Taisho Pharmaceutical Co., Ltd	Compuestos de isoxazoliltiofeno sustituidos.
US6521641B1 (en)	1998-10-08	2003-02-18	Allergan, Inc.	Male anti-fertility agents
US6288099B1 (en)	1998-12-04	2001-09-11	American Home Products Corporation	Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
AU4225500A (en) *	1999-04-14	2000-11-14	Allergan Sales, Inc.	Methods and compositions for the treatment and prevention of lung disease
US6043381A (en) *	1999-05-07	2000-03-28	Allergan Sales, Inc.	Process for preparing substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives
US20030125252A1 (en) *	2000-03-14	2003-07-03	Underhill T. Michael	Compositions and methods for affecting osteogenesis
US20020193403A1 (en)	2001-05-03	2002-12-19	Allergan Sales, Inc.	Methods of treating hyperlipidemia
KR20040054729A (ko) *	2001-10-18	2004-06-25	브리스톨-마이어스 스큅 컴퍼니	인간 글루카곤-유사-펩티드-1 모방체, 및 당뇨병 및 이와관련된 증상의 치료에 있어서 이의 용도
US7105566B2 (en)	2002-10-22	2006-09-12	Allergan, Inc.	Methods of treatment during vascular procedures
AU2004283196B2 (en)	2003-09-17	2011-08-25	Janssen Pharmaceutica, N.V.	Fused heterocyclic compounds
US20050261347A1 (en) *	2003-10-24	2005-11-24	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7435837B2 (en) *	2003-10-24	2008-10-14	Wyeth	Dihydrobenzofuranyl alkanamine derivatives and methods for using same
DE602004019685D1 (de)	2003-12-26	2009-04-09	Allergan Inc	DISUBSTITUIERTE CHALCOGENOXIME MIT ANTAGONISTISCHER WIRKUNG AM RAR(Gamma)-RETINOIDREZEPTOR
PE20061319A1 (es) *	2005-04-22	2006-12-28	Wyeth Corp	Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
BRPI0616454A2 (pt)	2005-09-30	2011-06-21	Vitae Pharmaceuticals Inc	métodos de tratamento de cáncer
ES2702128T3 (es)	2006-05-16	2019-02-27	Io Therapeutics Llc	Antagonista o agonista inverso de RAR para uso en el tratamiento de efectos secundarios de quimioterapia y/o terapia de radiación
AR065948A1 (es)	2007-04-06	2009-07-15	Neurocrine Biosciences Inc	Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
PE20090236A1 (es)	2007-04-06	2009-03-13	Neurocrine Biosciences Inc	Antagonistas de los receptores de la hormona liberadora de gonadotropina y procedimientos relacionados con ellos
JP5511786B2 (ja)	2008-03-31	2014-06-04	ジェネンテック，インコーポレイテッド	ベンゾピランおよびベンゾキセピンｐｉ３ｋ阻害剤化合物および使用方法
MX2012003591A (es)	2009-09-28	2012-04-19	Hoffmann La Roche	Compuestos de benzoxazepina como inhibidores de la pi3k y metodos de uso.
ES2558742T3 (es)	2009-09-28	2016-02-08	F. Hoffmann-La Roche Ag	Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
BR112013006016A2 (pt)	2010-09-15	2016-06-07	Hoffmann La Roche	compostos de azabenzotiazol, composições e métodos de uso
US9090628B2 (en)	2011-03-21	2015-07-28	Genentech, Inc.	Benzoxazepin compounds selective for PI3K P110 delta and methods of use
US20130190395A1 (en)	2011-12-13	2013-07-25	Dartmouth College	Autoimmune disorder treatment using rxr agonists
EP2909212B1 (en)	2012-09-07	2017-02-22	Takeda Pharmaceutical Company Limited	Substituted 1,4-dihydropyrazolo[4,3-b]indoles
AR103598A1 (es)	2015-02-02	2017-05-24	Forma Therapeutics Inc	Ácidos bicíclicos[4,6,0]hidroxámicos como inhibidores de hdac
MX2020003488A (es)	2015-02-02	2022-05-24	Forma Therapeutics Inc	Acidos 3-alquil-4-amido-biciclico [4,5,0] hidroxamicos como inhibidores de histona desacetilasas (hdac).
CN105061316B (zh) *	2015-07-17	2017-12-22	苏州大学	稠环类化合物、制备方法和用途
KR102489706B1 (ko)	2015-10-31	2023-01-17	아이오 테라퓨틱스, 인크.	Rxr 아고니스트와 갑상선 호르몬의 조합을 사용한 신경계 질환의 치료
ES2898676T3 (es)	2015-11-25	2022-03-08	Io Therapeutics Inc	Agonistas selectivos de rar-alfa resistentes a CYP26 en el tratamiento del cáncer
CN105418637A (zh) *	2015-12-08	2016-03-23	彭冬青	一种治疗甲亢的药物组合物
CA3016876C (en)	2016-03-10	2021-12-28	Io Therapeutics, Inc.	Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones
JP7169647B2 (ja)	2016-03-10	2022-11-11	アイオーセラピューティクスインコーポレイテッド	Ｒｘｒアゴニストおよび甲状腺ホルモンの組み合わせでの筋肉障害の治療
EP3468600A4 (en)	2016-06-10	2019-11-13	IO Therapeutics, Inc.	RETINOID COMPOUNDS AND RELECTIVE REXINOIDS OF THE RECEPTOR AND IMMUNE MODULATORS FOR IMMUNOTHERAPY OF CANCER
EP3472131B1 (en)	2016-06-17	2020-02-19	Forma Therapeutics, Inc.	2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
CN109485651B (zh) *	2017-06-29	2021-02-02	广西师范大学	2,3-稠环吲哚啉衍生物及其制备方法和应用
KR20200029544A (ko)	2017-07-13	2020-03-18	아이오 테라퓨틱스, 인크.	암 면역요법을 위해 면역 조절제와 조합된 면역조절 레티노이드 및 렉시노이드 화합물
AU2018326617B2 (en)	2017-08-31	2022-12-01	Io Therapeutics, Inc.	Rar selective agonists in combination with immune modulators for cancer immunotherapy
CA3035999C (en) *	2017-09-07	2021-01-05	Syaulan S. YANG	Benzene fused heterocyclic derivatives and pharmaceutical composition comprising the same
AU2018335393A1 (en)	2017-09-20	2020-04-02	Io Therapeutics, Inc.	Treatment of disease with esters of selective RXR agonists
US10966950B2 (en)	2019-06-11	2021-04-06	Io Therapeutics, Inc.	Use of an RXR agonist in treating HER2+ cancers
CA3235146A1 (en)	2021-10-14	2023-04-20	Incyte Corporation	Quinoline compounds as inhibitors of kras
US11896558B2 (en)	2021-12-07	2024-02-13	Io Therapeutics, Inc.	Use of an RXR agonist and taxanes in treating Her2+ cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3119819A (en) *	1959-07-29	1964-01-28	Ciba Geigy Corp	Intermediates for 18-o-alkyl-reserpic acid esters and related compounds
GB1071124A (en) *	1965-05-11	1967-06-07	Biorex Laboratories Ltd	Derivatives of pyrazolo-[4',5'-b]-11-oxo-18ª‡- and 18ª‰-olean-12-en-30-oic acid
FR2614618B1 (fr) *	1987-04-30	1989-07-07	Cird	Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
LU87040A1 (fr) *	1987-11-04	1989-06-14	Oreal	Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
DE3903993A1 (de) *	1989-02-10	1990-08-16	Basf Ag	Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
CA2029497C (en) *	1989-11-08	2002-06-04	Kunihiro Ninomiya (Deceased)	4-acylaminopyridine derivative

1993
- 1993-12-20 KR KR1019940703030A patent/KR0126300B1/ko active
- 1993-12-20 US US08/295,636 patent/US5612356A/en not_active Expired - Fee Related
- 1993-12-20 CA CA002129846A patent/CA2129846A1/en not_active Abandoned
- 1993-12-20 DK DK94903025.8T patent/DK0638071T3/da active
- 1993-12-20 DE DE69309670T patent/DE69309670T2/de not_active Expired - Fee Related
- 1993-12-20 ES ES94903025T patent/ES2102195T3/es not_active Expired - Lifetime
- 1993-12-20 EP EP94903025A patent/EP0638071B1/en not_active Expired - Lifetime
- 1993-12-20 WO PCT/JP1993/001841 patent/WO1994014777A1/en active IP Right Grant
- 1993-12-20 AT AT94903025T patent/ATE151418T1/de not_active IP Right Cessation
- 1993-12-21 JP JP32151793A patent/JP3476883B2/ja not_active Expired - Fee Related
- 1993-12-27 CN CN93121224A patent/CN1036920C/zh not_active Expired - Fee Related
1994
- 1994-08-26 FI FI943948A patent/FI943948A0/fi unknown
- 1994-08-26 NO NO934326A patent/NO304687B1/no not_active IP Right Cessation
- 1994-08-29 KR KR1019940703030A patent/KR950700258A/ko not_active IP Right Cessation
1997
- 1997-05-06 CN CN97111106A patent/CN1173497A/zh active Pending
- 1997-07-09 GR GR970401730T patent/GR3024074T3/el unknown
2003
- 2003-08-01 JP JP2003284757A patent/JP3992666B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR0126300B1 (ko)	1997-12-26
EP0638071A1 (en)	1995-02-15
CN1036920C (zh)	1998-01-07
CN1094052A (zh)	1994-10-26
JP2004043482A (ja)	2004-02-12
JP3992666B2 (ja)	2007-10-17
NO304687B1 (no)	1999-02-01
US5612356A (en)	1997-03-18
CA2129846A1 (en)	1994-07-07
DE69309670T2 (de)	1997-11-20
NO943165D0 (no)	1994-08-26
EP0638071B1 (en)	1997-04-09
CN1173497A (zh)	1998-02-18
WO1994014777A1 (en)	1994-07-07
DE69309670D1 (de)	1997-05-15
NO943165L (no)	1994-10-25
KR950700258A (ko)	1995-01-16
JPH06271545A (ja)	1994-09-27
DK0638071T3 (da)	1997-10-27
ES2102195T3 (es)	1997-07-16
GR3024074T3 (en)	1997-10-31
JP3476883B2 (ja)	2003-12-10
FI943948A0 (fi)	1994-08-26
ATE151418T1 (de)	1997-04-15

Publication	Publication Date	Title
FI943948A0 (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
DE69521424T2 (de)	2001-10-18	Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
DE69425431T2 (de)	2001-02-08	1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
NO950297D0 (no)	1995-01-26	Prolinamidderivater
ATE225770T1 (de)	2002-10-15	Difluoroprostaglandin-derivate und ihre anwendung
ES2149777T3 (es)	2000-11-16	Derivados de triazol que tienen actividad antifungica.
ES2121218T3 (es)	1998-11-16	Fenoxifenilciclopentenilhidroxiureas.
DK0646110T3 (da)	1996-11-18	N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
ES2094638T3 (es)	1997-01-16	N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
ZA9480B (en)	1994-08-11	Pyrrolidine derivatives their preparation and medicaments containing them
ES2116528T3 (es)	1998-07-16	Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.